Alzheimer's Drug Trial Altered After 9 Deaths
2009/12/15 01:09:22 @FOXNews.com
Elan Corp. Plc and Transition Therapeutics Inc. said Tuesday they've eliminated two of three doses used in a mid-stage study of a potential Alzheimer's disease treatment after nine patients died while receiving the higher doses. [ VIEW FULL COVERAGE @FOXNews.com ]